Siddiqui F, Vaqar S, Siddiqui AH. Lung Cancer. StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2024, StatPearls Publishing LLC.; 2024.

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

PubMed  Google Scholar 

Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–36.

PubMed  Google Scholar 

The Surveillance E, and End Results (SEER) Program. Cancer Stat Facts: Lung and Bronchus Cancer 2024 [Available from: https://seer.cancer.gov/statfacts/html/lungb.html.

O’Neil ME, Henley SJ, Rohan EA, Ellington TD, Gallaway MS. Lung cancer incidence in nonmetropolitan and metropolitan counties—United States, 2007–2016. MMWR Morb Mortal Wkly Rep. 2019;68(44):993–8.

PubMed  PubMed Central  Google Scholar 

GBDCRF Collaborators. The global burden of cancer attributable to risk factors 2010–19: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10352):563–91.

Google Scholar 

Mazi TA, Stanhope KL. Erythritol: an in-depth discussion of its potential to be a beneficial dietary component. Nutrients. 2023;15(1):204.

CAS  PubMed  PubMed Central  Google Scholar 

Liu F, Xia K, Chen Y, Zhu L, Zhu L, Zhao X, et al. Inhibition of hyphal formation together with biochar addition promotes erythritol production by Yarrowia lipolytica. Biotechnol Bioeng. 2024;121(6):1937–49.

CAS  PubMed  Google Scholar 

Witkowski M, Nemet I, Alamri H, Wilcox J, Gupta N, Nimer N, et al. The artificial sweetener erythritol and cardiovascular event risk. Nat Med. 2023;29(3):710–8.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang M, Wu S, Hu C. Do lung cancer patients require routine anticoagulation treatment? a meta-analysis. J Int Med Res. 2020;48(1):300060519896919.

PubMed  Google Scholar 

Qin Y, Zhang L, Liang X, Sun X, Wang N, Yuan M, et al. Venous and arterial thromboembolism in patients with metastatic lung cancer. Clin Appl Thromb Hemost. 2023;29:10760296231159120.

PubMed  PubMed Central  Google Scholar 

Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22.

PubMed  Google Scholar 

Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.

PubMed  Google Scholar 

Ortiz SR, Field MS. Mammalian metabolism of erythritol: a predictive biomarker of metabolic dysfunction. Curr Opin Clin Nutr Metab Care. 2020;23(5):296–301.

CAS  PubMed  Google Scholar 

Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362: k601.

PubMed  PubMed Central  Google Scholar 

Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023;55(1):44–53.

PubMed  PubMed Central  Google Scholar 

Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46(6):543–50.

CAS  PubMed  PubMed Central  Google Scholar 

McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet. 2017;49(7):1126–32.

CAS  PubMed  PubMed Central  Google Scholar 

Lin SH, Brown DW, Machiela MJ. LDtrait: an online tool for identifying published phenotype associations in linkage disequilibrium. Cancer Res. 2020;80(16):3443–6.

CAS  PubMed  PubMed Central  Google Scholar 

Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186.

PubMed  Google Scholar 

Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

CAS  PubMed  PubMed Central  Google Scholar 

Hemani G, Tilling K, Davey SG. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11): e1007081.

PubMed  PubMed Central  Google Scholar 

Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497–501.

PubMed  Google Scholar 

Schlicker L, Szebenyi DME, Ortiz SR, Heinz A, Hiller K, Field MS. Unexpected roles for ADH1 and SORD in catalyzing the final step of erythritol biosynthesis. J Biol Chem. 2019;294(44):16095–108.

CAS  PubMed  PubMed Central  Google Scholar 

Hootman KC, Trezzi JP, Kraemer L, Burwell LS, Dong X, Guertin KA, et al. Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults. Proc Natl Acad Sci U S A. 2017;114(21):E4233–40.

CAS  PubMed  PubMed Central  Google Scholar 

Ge T, Yang J, Zhou S, Wang Y, Li Y, Tong X. The role of the pentose phosphate pathway in diabetes and cancer. Front Endocrinol. 2020;11:365.

Google Scholar 

Ortiz SR, Heinz A, Hiller K, Field MS. Erythritol synthesis is elevated in response to oxidative stress and regulated by the non-oxidative pentose phosphate pathway in A549 cells. Front Nutr. 2022;9: 953056.

PubMed  PubMed Central  Google Scholar 

Iatridis N, Kougioumtzi A, Vlataki K, Papadaki S, Magklara A. Anti-cancer properties of Stevia rebaudiana; more than a sweetener. Molecules. 2022;27(4):1362.

CAS  PubMed  PubMed Central  Google Scholar 

Khare N, Chandra S. Stevioside mediated chemosensitization studies and cytotoxicity assay on breast cancer cell lines MDA-MB-231 and SKBR3. Saudi J Biol Sci. 2019;26(7):1596–601.

CAS  PubMed  Google Scholar 

Chen J, Xia Y, Sui X, Peng Q, Zhang T, Li J, et al. Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively. Oncotarget. 2018;9(41):26299–308.

PubMed  PubMed Central  Google Scholar 

Jain R, Hussein MA, Pierce S, Martens C, Shahagadkar P, Munirathinam G. Oncopreventive and oncotherapeutic potential of licorice triterpenoid compound glycyrrhizin and its derivatives: molecular insights. Pharmacol Res. 2022;178: 106138.

CAS  PubMed  PubMed Central  Google Scholar 

Luo P, Liu D, Li J. Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19. Int J Antimicrob Agents. 2020;55(6): 105995.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Xu M, Sun X, Guo X. Naturally occurring glycyrrhizin triterpene exerts anticancer effects on colorectal cancer cells via induction of apoptosis and autophagy and suppression of cell migration and invasion by targeting MMP-9 and MMP-2 expression. J BUON. 2020;25(1):188–93.

PubMed  Google Scholar 

Sylvetsky AC, Jin Y, Clark EJ, Welsh JA, Rother KI, Talegawkar SA. Consumption of low-calorie sweeteners among children and adults in the United States. J Acad Nutr Diet. 2017;117(3):441–8.

PubMed  PubMed Central  Google Scholar 

Riess LE, Huynh BQ, Nachman KE. Aspartame exposures in the US population: Demonstration of a novel approach for exposure estimates to food additives using NHANES data. J Expo Sci Environ Epidemiol. 2024.

Patil S, Jalal RAS, Albar DH, Bansal SJ, Patil S, Nagaral S, et al. Intake of artificial sweeteners by children: boon or bane? J Contemp Dent Pract. 2023;24(2):137–45.

PubMed  Google Scholar 

Debras C, Chazelas E, Sellem L, Porcher R, Druesne-Pecollo N, Esseddik Y, et al. Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Sante cohort. BMJ. 2022;378: e071204.

PubMed  PubMed Central  Google Scholar 

Debras C, Chazelas E, Srour B, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, et al. Artificial sweeteners and cancer risk: results from the NutriNet-Sante population-based cohort study. PLoS Med. 2022;19(3):e1003950.

CAS  PubMed  PubMed Central  Google Scholar 

Tepler A, Hoffman G, Jindal S, Narula N, Shah SC. Intake of artificial sweeteners among adults is associated with reduced odds of gastrointestinal luminal cancers: a meta-analysis of cohort and case-control studies. Nutr Res. 2021;93:87–98.

CAS  PubMed  PubMed Central  Google Scholar